Clinical trials
Completed Pain trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
124 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 8 |
| 2011 | 16 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 9 |
| 2016 | 5 |
| 2017 | 15 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 124 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal University of São Paulo | 19 |
| University of Sao Paulo | 19 |
| University of Sao Paulo General Hospital | 6 |
| Universidade Federal de Sao Carlos | 5 |
| Hospital de Clinicas de Porto Alegre | 4 |
| University of Nove de Julho | 4 |
| Federal University of the Valleys of Jequitinhonha and Mucuri | 3 |
| Universidade Federal de Pernambuco | 3 |
| Universidade Federal do Para | 3 |
| Centro Universitário Augusto Motta | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pain | 124 |
| Agnosia | 9 |
| Low Back Pain | 8 |
| Fibromyalgia | 7 |
| Neuralgia | 6 |
| Osteoarthritis, Knee | 6 |
| Edema | 5 |
| Postoperative Pain | 5 |
| Breast Neoplasms | 4 |
| Chronic Pain | 4 |
Trials
Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.
24 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.